PT1289999E - Analogos antitumorais de et-743 - Google Patents

Analogos antitumorais de et-743

Info

Publication number
PT1289999E
PT1289999E PT01929813T PT01929813T PT1289999E PT 1289999 E PT1289999 E PT 1289999E PT 01929813 T PT01929813 T PT 01929813T PT 01929813 T PT01929813 T PT 01929813T PT 1289999 E PT1289999 E PT 1289999E
Authority
PT
Portugal
Prior art keywords
hydroxy
spiroamine
protecting group
bridge
ecteinascidin
Prior art date
Application number
PT01929813T
Other languages
English (en)
Inventor
Carmen Pharma Mar S A Cuevas
Ignacio Pharma Mar Manzanares
Marta Pharma Mar S A Perez
Maria Jesus Pharma Mar Martin
Alberto Pharma Mar S Rodriguez
Simon Pharma Mar S A Munt
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2000/001852 external-priority patent/WO2000069862A2/en
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of PT1289999E publication Critical patent/PT1289999E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D497/00Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/22Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D515/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Discharging, Photosensitive Material Shape In Electrophotography (AREA)
  • Instruments For Viewing The Inside Of Hollow Bodies (AREA)
PT01929813T 2000-05-15 2001-05-15 Analogos antitumorais de et-743 PT1289999E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/GB2000/001852 WO2000069862A2 (en) 1999-05-14 2000-05-15 Hemisynthetic method and intermediates thereof
PCT/GB2001/002110 WO2001087894A1 (en) 1999-05-14 2001-05-15 Antitumoral analogs of et-743

Publications (1)

Publication Number Publication Date
PT1289999E true PT1289999E (pt) 2005-03-31

Family

ID=34855248

Family Applications (3)

Application Number Title Priority Date Filing Date
PT01929813T PT1289999E (pt) 2000-05-15 2001-05-15 Analogos antitumorais de et-743
PT04010399T PT1496060E (pt) 2000-05-15 2001-05-15 Análogos antitumurais de et-743
PT01929816T PT1287004E (pt) 2000-05-15 2001-05-15 Processo sintetico para a producao de um composto ecteinascidina

Family Applications After (2)

Application Number Title Priority Date Filing Date
PT04010399T PT1496060E (pt) 2000-05-15 2001-05-15 Análogos antitumurais de et-743
PT01929816T PT1287004E (pt) 2000-05-15 2001-05-15 Processo sintetico para a producao de um composto ecteinascidina

Country Status (16)

Country Link
EP (3) EP1289999B1 (pt)
KR (2) KR100830717B1 (pt)
AT (2) ATE300547T1 (pt)
AU (2) AU2001256496C1 (pt)
DE (3) DE60129753T2 (pt)
DK (3) DK1289999T3 (pt)
EA (2) EA006369B1 (pt)
ES (2) ES2290583T3 (pt)
GB (1) GB9918178D0 (pt)
HU (1) HU228789B1 (pt)
MX (1) MXPA02010701A (pt)
NZ (2) NZ532793A (pt)
PL (1) PL203745B1 (pt)
PT (3) PT1289999E (pt)
SI (2) SI1496060T1 (pt)
UA (1) UA75597C2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE368461T1 (de) 2004-10-29 2007-08-15 Pharma Mar Sa Zusammensetzungen enthaltend ecteinascidin und einen disaccharide
KR100676324B1 (ko) * 2005-03-15 2007-01-30 삼성전자주식회사 디스플레이장치
KR100676325B1 (ko) * 2005-03-15 2007-01-30 삼성전자주식회사 디스플레이장치
KR100712667B1 (ko) * 2006-04-11 2007-05-02 재단법인서울대학교산학협력재단 신규한 디아자 헤테로고리 유도체 및 그의 고체상 제조방법
CN103038240A (zh) * 2010-05-25 2013-04-10 法马马有限公司 制备海鞘素化合物的合成方法
KR102491180B1 (ko) 2017-04-27 2023-01-20 파르마 마르 에스.에이. 항종양 화합물
WO2020105068A1 (en) * 2018-11-24 2020-05-28 Natco Pharma Limited Process for the preparation of ecteinascidin derivative and its intermediate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59225189A (ja) 1983-06-03 1984-12-18 Shionogi & Co Ltd キノナミン誘導体およびその製造法
EP0309477B1 (en) * 1986-06-09 1991-11-06 The Board Of Trustees Of The University Of Illinois Ecteinascidins 729, 743, 745, 759a, 759b and 770
US5721362A (en) * 1996-09-18 1998-02-24 President And Fellows Of Harvard College Process for producing ecteinascidin compounds
US6124292A (en) * 1998-09-30 2000-09-26 President And Fellows Of Harvard College Synthetic analogs of ecteinascidin-743

Also Published As

Publication number Publication date
HUP0300648A3 (en) 2006-05-29
NZ521807A (en) 2004-06-25
EA006070B1 (ru) 2005-08-25
EP1289999B1 (en) 2004-11-17
EP1496060B1 (en) 2007-08-01
DE60129753T2 (de) 2008-04-30
DK1496060T3 (da) 2007-12-03
EP1496060A1 (en) 2005-01-12
HUP0300648A2 (hu) 2003-07-28
ES2290583T3 (es) 2008-02-16
DE60129753D1 (de) 2007-09-13
UA75597C2 (en) 2006-05-15
AU2001256496C1 (en) 2006-08-03
ATE300547T1 (de) 2005-08-15
KR20030031481A (ko) 2003-04-21
PL203745B1 (pl) 2009-11-30
DK1287004T3 (da) 2005-11-28
SI1496060T1 (sl) 2008-06-30
HU228789B1 (en) 2013-05-28
GB9918178D0 (en) 1999-10-06
MXPA02010701A (es) 2003-05-14
EP1287004B1 (en) 2005-07-27
NZ532793A (en) 2004-10-29
AU2001256496B2 (en) 2006-02-16
PT1496060E (pt) 2007-10-30
AU5649301A (en) 2001-11-26
KR100830717B1 (ko) 2008-05-20
PT1287004E (pt) 2005-11-30
KR20030005308A (ko) 2003-01-17
DE60107241D1 (de) 2004-12-23
EP1289999A1 (en) 2003-03-12
DE60112286T2 (de) 2006-06-01
ES2248319T3 (es) 2006-03-16
DE60107241T2 (de) 2006-08-03
HK1050193A1 (en) 2003-06-13
EA200201210A1 (ru) 2003-04-24
EP1287004A1 (en) 2003-03-05
SI1289999T1 (en) 2005-06-30
PL358143A1 (pl) 2004-08-09
KR100777464B1 (ko) 2007-11-27
EA200201209A1 (ru) 2003-04-24
AU783563B2 (en) 2005-11-10
DK1289999T3 (da) 2005-03-14
ATE368671T1 (de) 2007-08-15
DE60112286D1 (de) 2005-09-01
EA006369B1 (ru) 2005-12-29

Similar Documents

Publication Publication Date Title
PL358258A1 (en) Antitumoral analogs of et-743
BR9916027A (pt) Análogos de glp-1
BR9915961A (pt) Análogos de glp-1
ATE527247T1 (de) Benzokondensierte 5gliedrige heterocyclische verbindungen, verfahren zu deren herstellung und deren verwendung
BRPI0407507A (pt) derivados de hexahidro-pirazino[1,2-a]pirimidin-4,7-diona, processos para sua preparação de sua aplicação como medicamento
BR0111263A (pt) Derivados de 2-aminocarbonil-9h-purina
BRPI0407387A (pt) Derivados de hexahidro-pirazino[1,2-a]pirimidin-4,7-diona substituìdos por nitrogênio, processos para a sua preparação e sua aplicação com medicamento
LU91206I2 (fr) Ceftiofur sous forme d'acide libre cristallin et ses dérivés pharmaceutiquement acceptables (naxcel)
BR9815166A (pt) "método de inibição da replicação de vìrus, composto, método de inibição da replicação de citomegalovìrus, composto antiviral, utilização de um composto, composição farmacêutica, composição farmacêutica inibidora da replicação de vìrus e de citomegalovìrus e composição farmacêutica antiviral"
ES2003671A6 (es) Un procedimiento para preparar derivados de dihidrobenzo-furano- y cromano-carboxamidas
PT1289999E (pt) Analogos antitumorais de et-743
BR9507231A (pt) Uso de derivados de ácido carboxílico para a produção de drogas
DE69434652D1 (de) Antikonvulsive pseudofructopyranose sulfamate
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
SE0004462D0 (sv) Novel method and use
BR0017175A (pt) Modificação da torasemida amorfa
BR9611572A (pt) Produção de um sal de ácido clavulânico
DK0690855T3 (da) Benzopyraner som kaliumkanalåbnere
SE9704834D0 (sv) New process
DE69411380D1 (de) Neue heterocyclische acyldipeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung